Highlights
- Third quarter 2026 Net Income was $361,107 thousand, or $4.62 per diluted share, compared with $387,843 thousand, or $4.73.
- Third quarter total premium was $1,311,409 thousand, compared with $1,231,007 thousand, and total Revenue was $1,595,937 thousand.
- Management expects 2026 net operating Earnings per diluted share of $15.35 to $15.65, a decrease from prior guidance.
- Globe Life repurchased 3.6 million shares for $564 million in nine months, at an average share price of $155.30.
Globe Life Inc. (NYSE:GL) shares were trading at USD 158.98 on November 17, 2026, down 0.26%, with a relative Volume at time of 1.74. The insurance Holding Company discussed third quarter 2026 results and lowered its 2026 earnings guidance on an October 22 call, then filed its Form 10-Q on November 4, which discloses a residential Mortgage Loan Investment program with an initial commitment of up to $250 million.
Globe Life is a Delaware corporation incorporated in 1979, with principal executive offices in McKinney, Texas. It is the holding company for a group of insurance companies that market through exclusive, direct-to-consumer and independent distribution channels, primarily individual life and supplemental Health Insurance to lower middle to middle-income households throughout the United States. It reports life and supplemental health product line segments and an investment segment. Its fiscal year ends December 31.
Third Quarter Results
For the quarter ended September 30, 2026, Globe Life reported total revenue of $1,595,937 thousand, compared with $1,512,988 thousand a year earlier. Life premium was $864,552 thousand, compared with $844,483 thousand, and health premium was $446,857 thousand, compared with $386,524 thousand. Net investment income was $295,895 thousand, compared with $286,013 thousand, and realized losses were $12,612 thousand, compared with $4,987 thousand.
Income before income taxes was $441,234 thousand, compared with $477,102 thousand. Net income was $361,107 thousand, compared with $387,843 thousand, and diluted net income per share was $4.62, compared with $4.73. The company recorded a $120.5 million net remeasurement gain from its annual assumptions review, compared with $134.3 million a year earlier.
On the call, management said net operating income, a non-GAAP measure, was $379 million, or $4.84 per share, compared with $4.81. It said United American's health Underwriting Margin was negative $6 million, compared with $16 million, citing nearly $7 million of Medicare supplement claims from prior periods tied to a CMS processing delay and an underwriting loss of nearly $16 million at Evri.
Nine-Month Results and Capital
For the nine months, net income was $919,380 thousand, or $11.64 per diluted share, compared with $895,155 thousand, or $10.77. Net operating income, a non-GAAP measure, was $937 million, compared with $925 million.
At September 30, 2026, total Assets were $30,570,417 thousand, compared with $30,813,692 thousand at December 31, 2025. Total shareholders' Equity was $6,618,484 thousand, compared with $5,974,579 thousand, and Book Value per share was $85.35. Long-term Debt was $2,667,769 thousand, compared with $2,320,793 thousand.
Globe Life repurchased 3.6 million shares at a total cost of $564 million. On the call, management said third quarter repurchases cost approximately $185 million at an average price of $175.61. Common dividends declared were $0.33 per share in each quarter of 2026.
Litigation and Subsequent Event
The 10-Q discloses a putative securities class action against Globe Life and current and former executives and directors in the U.S. District Court for the Eastern District of Texas. Lead plaintiffs moved for class certification on May 15, 2026, and the company said it plans to defend the lawsuit vigorously. The 10-Q also describes several related Shareholder derivative suits. After September 30, 2026, the company approved a residential mortgage loan investment program with an initial commitment of up to $250 million.
2026 and 2027 Outlook
On the call, management said it expects 2026 net operating earnings per diluted share, a non-GAAP measure, of $15.35 to $15.65, a decrease from prior guidance that reflects third quarter results and revised fourth quarter margin estimates for United American. It expects total premium revenue growth of around 6.5% for 2026 and share repurchases of $725 million to $775 million, with approximately $185 million in the fourth quarter. For 2027, management expects net operating earnings per diluted share of $16.10 to $17.10 and total premium revenue growth of 6% to 8%.


_11_20_2026_12_40_53_605100.jpg)



Please wait processing your request...